Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
DRUG
Alvircept sudotox
Trial Locations (1)
943055107
Stanford Univ Med Ctr, Stanford
All Listed Sponsors
lead
Pharmacia and Upjohn
INDUSTRY
NCT00002087 - Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals | Biotech Hunter | Biotech Hunter